5051-201
Research payments
$3,134,333
Through program year 2025, $3,134,333 in research payments was reported against 5051-201, across 283 payments, paid by Sarepta Therapeutics, Inc..
- Paid by
- Sarepta Therapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,360,948 | 160 |
| 2024 | Research | $1,670,455 | 122 |
| 2023 | Research | $102,929 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Han Phan Atlanta, GA Named on 67 payments
- Susan Iannaccone Dallas, TX Named on 52 payments
- Brenda Wong Worcester, MA Named on 35 payments
- Hoda Abdel Hamid Pittsburgh, PA Named on 20 payments
- Katherine Mathews Iowa City, IA Named on 19 payments
- Weldon Mauney Gulf Breeze, FL Named on 16 payments
- Seth Perlman Seattle, WA Named on 15 payments
- Craig McDonald Sacramento, CA Named on 15 payments
- Gyula Acsadi Detroit, MI Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.